SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051239
Filing Date
2020-11-05
Accepted
2020-11-05 15:30:38
Documents
75
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20200930.htm   iXBRL 10-Q 2609450
2 EX-31.1 syrs-ex311_9.htm EX-31.1 17652
3 EX-31.2 syrs-ex312_6.htm EX-31.2 17642
4 EX-32.1 syrs-ex321_8.htm EX-32.1 5971
5 EX-32.2 syrs-ex322_7.htm EX-32.2 6078
  Complete submission text file 0001564590-20-051239.txt   9452474

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA syrs-20200930.xsd EX-101.SCH 65402
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20200930_cal.xml EX-101.CAL 61932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20200930_def.xml EX-101.DEF 222358
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20200930_lab.xml EX-101.LAB 504123
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20200930_pre.xml EX-101.PRE 408843
11 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10q_20200930_htm.xml XML 1745589
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 201290162
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences